Lacombe M J, Llombart-Bosch A, Lecluse Y, Bertin F, Contesso G
Ann Pathol. 1986;6(1):37-44.
We report 7 cases of unusual fibroadenomas of the breast. They are characterized by an exuberant cellular proliferation within the ductal lumens. They appear in young women from 20 to 40 years old. These lesions are histologically identical to those described by Azzopardi (1979) under the name of "Argyrophilic cells in fibroadenomas" and by Eusebi and Azzopardi (1980) and by Govoni (1981) and called "Lobular endocrine neoplasia in fibroadenoma of the Breast". An immunohistochemical study reveals a major positivity of these cells, in all cases, with Antikeratin Antibody (anti Kl1) and with Epithelial Membrane Antigen (anti EMA) proving the epithelial origin of these cells. There cells cannot yet be regarded as belonging to the neuro-endocrine group, because of the negativity, in all cases of Grimelius and Bodian stains, and of the very heterogeneous positivity observed with Neuron-Specific Enolase antibody (anti NSE) and with anti Human Natural Killer antibody (anti HNK). These cellular proliferations seem to us, on the microscopical point of view related to the atypical epithelial hyperplasias of the breast, and different from the in situ lobular carcinoma. Thus we propose to call these lesions "variant of the breast fibroadenoma" characterized by an atypical epithelial clear cell hyperplasia. The treatment of these lesions merely consists of a lumpectomy. Only one case is associated with an eleven years free of disease follow-up: a follow-up comprised between on to fifteen months is observed in the others cases. The knowledge of these benign lesions appears to us very important, to avoid improper treatment caused by an erroneous diagnosis of carcinoma developing in a breast fibroadenoma.
我们报告了7例不寻常的乳腺纤维腺瘤。其特征是导管腔内细胞增生旺盛。它们出现在20至40岁的年轻女性中。这些病变在组织学上与Azzopardi(1979年)以“纤维腺瘤中的嗜银细胞”之名描述的病变、Eusebi和Azzopardi(1980年)以及Govoni(1981年)所描述并称为“乳腺纤维腺瘤中的小叶内分泌瘤变”的病变相同。免疫组织化学研究显示,在所有病例中,这些细胞对抗角蛋白抗体(抗Kl1)和上皮膜抗原(抗EMA)呈主要阳性,证明这些细胞的上皮起源。由于在所有病例中Grimelius和Bodian染色均为阴性,以及用神经元特异性烯醇化酶抗体(抗NSE)和抗人类自然杀伤抗体(抗HNK)观察到的非常异质性的阳性,这些细胞尚不能被视为属于神经内分泌组。从显微镜角度看,这些细胞增生似乎与乳腺非典型上皮增生有关,与原位小叶癌不同。因此,我们建议将这些病变称为“乳腺纤维腺瘤变异型”,其特征为非典型上皮透明细胞增生。这些病变的治疗仅包括肿块切除术。只有1例患者有11年无病随访:其他病例的随访时间为1至15个月。对我们来说,了解这些良性病变非常重要,以避免因乳腺纤维腺瘤中误诊为癌而导致的不适当治疗。